Two Sigma Securities, LLC Cidara Therapeutics, Inc. Transaction History

Two Sigma Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.68 - $0.97 $24,943 - $35,580	36,681 New	36,681 $28,000
Q1 2023 May 15, 2023	BUY	$0.75 - $1.98 $8,694 - $22,952	11,592 New	11,592 $14,000
Q3 2022 Nov 14, 2022	BUY	$0.45 - $13.0 $18,818 - $543,647	41,819 New	41,819 $26,000
Q3 2019 Nov 14, 2019	SELL	$1.25 - $2.35 $16,130 - $30,324	-12,904 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.49 - $2.94 $19,226 - $37,937	12,904 New	12,904 $22,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.63B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.